Ann: 4DMedical secures national contract with I-MED, page-37

"As well as being used to assist in diagnosis, the unique capability and low-dosage modality developed by 4DMedical is also proving particularly useful as a surveillance tool in understanding lung disease."

They keep reiterating this subtle point implying that the real revenue generation will come not from the primary diagnosis, but from recurring monitoring of repeat patients, and when coupled with the newly impaired could grow exponentially.

This contract also validates the XV software which many thought no better than a CT scan or Xray. Like we’ve discussed previously, this is a new modality offering a fresh insight into the form and function of the lungs (not simply structure as CT does) providing physicians the capacity to diagnose and manage patients with varying respiratory ailments. Plenty of room for 4DX to thrive among other diagnostic tools given their >90% gross margin.